Aging decreases beta-endorphin enhancement of T-cell mitogenesis in mice.
Numerous studies have demonstrated the role of the central nervous system in immunomodulation. beta-Endorphin, a neuropeptide that is released along with adrenocorticotropin by the pituitary in response to stress, has been shown to have various effects on immune function, although these effects are dependent on dose, animal model, and immune cell tested. Since the increased risk for infection and tumor that is observed in the elderly is thought to be in part secondary to waning cell-mediated immunity, we investigated the effect of age on beta-endorphin immunomodulation of T-cell proliferation in a murine model. Spleen cells obtained from young and old BALB/c mice were cultured in vitro with various mitogens with and without beta-endorphin. beta-Endorphin at 10(-8) M on day 3 of culture significantly enhanced concanavalin A (2.0 micrograms/10(6) cells per ml) mitogenesis but not phytohemagglutinin or lipopolysaccharide mitogenesis. Moreover, this enhancement was shown only in spleen cells from young mice and was not blocked by the opiate receptor antagonist naloxone, which suggests that enhancement of mitogenesis by beta-endorphin was mediated by a non-opiate receptor. Finally, our results support an altered response to neuroimmunomodulation with age.
Norman
D C
DC
Geriatric Research, Education and Clinical Center (GRECC), VA Medical Center West Los Angeles, CA 90073.
Morley
J E
JE
Chang
M P
MP
D000375:Aging; D000818:Animals; D003208:Concanavalin A / Q000494:pharmacology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009270:Naloxone / Q000494:pharmacology; D015213:Neuroimmunomodulation; D013601:T-Lymphocytes / Q000187:drug effects*; D001615:beta-Endorphin / Q000494:pharmacology*
D003208:Concanavalin A; D009270:Naloxone; D001615:beta-Endorphin